首页> 美国政府科技报告 >Combined Contrast-Enhanced MRI and Fluorescence Molecular Tomography for Breast Tumor Imaging; Annual summary rept. 15 Feb 2007-14 Feb 2008
【24h】

Combined Contrast-Enhanced MRI and Fluorescence Molecular Tomography for Breast Tumor Imaging; Annual summary rept. 15 Feb 2007-14 Feb 2008

机译:联合对比增强mRI和荧光分子断层扫描用于乳腺肿瘤成像;年度总结报告。 2007年2月15日至2008年2月14日

获取原文

摘要

A unique fluorescence molecular tomography system which couples fluorescence data acquisition into the bore of a clinical MRI to image the spatial distribution of fluorescence activity in tissue volumes has been developed and characterized. Signal-to-noise and system sensitivity to fluorophore concentration have been studied extensively. In homogeneous 70mm diameter cylindrical phantoms, the system shows a linear response to fluorophore concentration down to 1nM and is sensitive down to 10pM. Images in realistic phantoms simulating breast tissue reveal the importance of the complimentary MRI information, especially in cases where the tumor to normal tissue fluorophore uptake is less than perfect. Reconstructing images using tissue morphology information from simultaneously acquired MRI images recover tumor regions down to contrasts of 1.5 to 1 while images reconstructed without the MR information show no tumor specificity even at contrasts above 6 to 1.

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号